Welcome to the OniX OnPoint Newsletter, your weekly window into the cutting-edge world of biomedical innovation. At OniX Hub, we're committed to bridging the gap between groundbreaking research and real-world applications.

This week OnPoint # 7 issue table of contact is below:

Technology Transfer:

1. ARH3, A Therapeutic Target for Cancer, Ischemia, and Inflammation – USA

2. Novel Methods for Generating Regulatory T-Cells – USA

3. Novel MRGPRX2 Antagonists for Itch and Inflammation – USA

4. Targeting Osteopontin: Novel Strategy to Treat Cancer and Inflammation – USA

5. Biomarker to Enrich for Inflammation-Resistant Cartilage to Treat Osteoarthritis – USA

6. A First-in-Class Peptide Immunotherapy for Type 1 Diabetes – United Kingdom

7. Phenolic Compound to Treat Diabetes – France

8. Agonists for GPR55 as Multi-Disease Targets – Canada

9. A Clonal Stable Cell Line for Human P2X3 Ligands – Canada

10. Novel ssDNA Anti-Mincle Aptamer – Canada

Sponsored Projects:

1. Elucidating Molecular Mechanisms of Irisin-Mediated Effects – USA

2. B Cell-T Cell Crosstalk in Celiac Disease – USA

3. Evaluating Notch Signaling in Chronic Pancreatitis – USA

4. Examining Molecular Regulation of Protein Secretion – USA

5. The Role of Dermal Nociceptors in Atopic Dermatitis – France

6. Negative Regulation of Inflammation and Aging – Switzerland

7. Skin and Gut Inflammation Connection – Netherlands

8. Balance Between Kinin B1 and B2 Receptors in Fibrosis – Brazil

9. Role of RNA-Binding Protein in Activating Anti-Tumor Immunity – Japan

10. Angiotensin-(1-7) Glycopeptide for Dementia in Parkinson's Disease – USA

Startups:

1. BioTherapeutics Inc – USA

2. EpiCypher – USA

3. AmacaThera – Canada

4. Aramis Biotechnologies – Canada

5. Myricx Bio – United Kingdom

6. Minoryx Therapeutics – Spain

7. SynOx Therapeutics Ltd – Ireland

8. Resalis Therapeutics – Italy

9. The Protein Brewery – Netherlands

10. AMSilk GmbH – Germany

VC Funding:

1. Diakonos Oncology – USA

2. Superluminal Medicines, Inc. – USA

3. NanoSyrinx – United Kingdom

4. PhoreMost Ltd. – United Kingdom

5. Candid Therapeutics – USA

News:

1. ARID3A: The Master Switch for Intestinal Healing and Cell Renewal

Subscription plans are available to receiving this valuable industry intelligence.
OniX OnPoint serves as your portal to the vast resources of OniX Hub. Whether you're seeking licensing opportunities, potential partnerships, or investment prospects, we're here to facilitate connections that drive progress in healthcare and life sciences.
We're committed to evolving this newsletter based on your feedback, always aiming to deliver the most relevant insights on biomedical innovation. Let's explore this week's most exciting developments in the field.